David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Quest Diagnostics
DGX
$26.9B
| $36.2M | 0.03% |
281,819
+184,722
| +190% | +$22.8M |
|
577
Corpay
CPAY
$27.3B
| $36.1M | 0.03% |
134,308
+17,661
| +15% | +$4.8M |
|
578
Incyte
INCY
$25.9B
| $35.8M | 0.03% |
440,568
+99,456
| +29% | +$8.49M |
|
579
Heron Therapeutics
HRTX
$59.9M
| $35.8M | 0.03% |
2,207,390
-53,888
| -2% | -$961K |
|
580
PUT
Meta Platforms (Facebook)
META
$1.41T
| $35.8M | 0.03% |
121,400
-113,900
| -48% | -$30.7M |
|
581
Tapestry
TPR
$26.4B
| $35.7M | 0.03% |
867,424
-1,336,444
| -61% | -$51.5M |
|
582
C.H. Robinson
CHRW
$16.7B
| $35.7M | 0.03% |
374,169
-2,719
| -0.7% | -$254K |
|
|
CHNGU
583
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $35.7M | 0.03% |
480,259
+180,259
| +60% | +$14.1M |
|
584
CALL
Lyft
LYFT
$6.69B
| $35.5M | 0.03% |
561,500
+253,200
| +82% | +$14.1M |
|
585
CALL
Lockheed Martin
LMT
$130B
| $35.3M | 0.03% |
95,600
-19,500
| -17% | -$6.69M |
|
586
Green Plains
GPRE
$1.04B
| $35.3M | 0.03% |
1,302,818
+8,496
| +0.7% | +$195K |
|
587
CALL
BP
BP
$113B
| $35.1M | 0.03% |
1,440,200
+665,700
| +86% | +$16M |
|
588
CDW
CDW
$16.8B
| $34.9M | 0.03% |
210,816
-42,710
| -17% | -$6.38M |
|
589
CALL
AbbVie
ABBV
$469B
| $34.9M | 0.03% |
322,600
-291,400
| -47% | -$31.2M |
|
590
Brookfield Renewable
BEPC
$6.09B
| $34.8M | 0.03% |
744,016
+297,708
| +67% | +$15.2M |
|
591
TripAdvisor
TRIP
$1.2B
| $34.8M | 0.03% |
646,828
+359,502
| +125% | +$15.4M |
|
592
PUT
DexCom
DXCM
$34.6B
| $34.8M | 0.03% |
387,200
-44,800
| -10% | -$4.21M |
|
593
Eaton
ETN
$159B
| $34.7M | 0.03% |
251,073
+131,544
| +110% | +$17M |
|
594
PUT
Chevron
CVX
$398B
| $34.7M | 0.03% |
330,900
-207,000
| -38% | -$20.2M |
|
595
ResMed
RMD
$33.5B
| $34.4M | 0.03% |
177,184
+173,932
| +5,348% | +$34.9M |
|
596
Trimble
TRMB
$14.1B
| $34.3M | 0.03% |
441,102
-823,658
| -65% | -$59.5M |
|
597
Zions Bancorporation
ZION
$9.9B
| $34.3M | 0.03% |
623,290
+254,188
| +69% | +$13.1M |
|
|
598
CALL
Chevron
CVX
$398B
| $34.2M | 0.03% |
326,000
-172,000
| -35% | -$16.8M |
|
599
Equitable Holdings
EQH
$13.4B
| $34.2M | 0.03% |
1,047,093
-151,608
| -13% | -$4.37M |
|
|
GFLU
600
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $34.1M | 0.03% |
418,246
+288,500
| +222% | +$21.2M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.